Efficacy, safety and response predictors of adjuvant Astragalus therapy for diabetic kidney disease – an open-label randomised controlled trial with responder regression analysis
Grant Data
Project Title
Efficacy, safety and response predictors of adjuvant Astragalus therapy for diabetic kidney disease – an open-label randomised controlled trial with responder regression analysis
Principal Investigator
Professor Tang, Sydney Chi Wai
(Principal Investigator (PI))
Co-Investigator(s)
Dr Chan Kam Wa
(Co-Investigator)
Dr Zhang Yanbo
(Co-Investigator)
Duration
54
Start Date
2017-07-18
Completion Date
2024-07-02
Amount
1199954
Conference Title
Efficacy, safety and response predictors of adjuvant Astragalus therapy for diabetic kidney disease – an open-label randomised controlled trial with responder regression analysis
Keywords
astragalus, Chinese medicine, clinical trial, diabetic nephropathy, integrative medicine, predictive analysis
Discipline
Others - Medicine, Dentistry and Health
HKU Project Code
14151731
Grant Type
Health and Medical Research Fund - Full Grant
Funding Year
2016
Status
Completed
Objectives
To evaluate the effect of add-on astragalus treatment and the corresponding effect predictors for type 2 diabetic patients with stages 2 to 3 chronic kidney disease and macroalbuminuria.